Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Consolidated Net Income: 2016-2019

Historic Consolidated Net Income for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to -$4.3 million.

  • Monopar Therapeutics' Consolidated Net Income fell 32.23% to -$1.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$4.3 million, marking a year-over-year decrease of 36.88%. This contributed to the annual value of -$4.3 million for FY2019, which is 31.04% down from last year.
  • Per Monopar Therapeutics' latest filing, its Consolidated Net Income stood at -$4.3 million for FY2019, which was down 31.04% from -$3.3 million recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' Consolidated Net Income registered a high of -$1.2 million during FY2016, and its lowest value of -$16.6 million during FY2017.
  • Moreover, its 3-year median value for Consolidated Net Income was -$4.3 million (2019), whereas its average is -$8.1 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 1,287.87% in 2017, then skyrocketed by 80.07% in 2018.
  • Over the past 4 years, Monopar Therapeutics' Consolidated Net Income (Yearly) stood at -$1.2 million in 2016, then slumped by 1,287.87% to -$16.6 million in 2017, then soared by 80.07% to -$3.3 million in 2018, then tumbled by 31.04% to -$4.3 million in 2019.